+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Single Use Bioreactors"

From
Antibody Production - Global Strategic Business Report - Product Thumbnail Image

Antibody Production - Global Strategic Business Report

  • Report
  • April 2025
  • 103 Pages
  • Global
From
From
From
From
From
From
Upstream Bioprocessing - Global Strategic Business Report - Product Thumbnail Image

Upstream Bioprocessing - Global Strategic Business Report

  • Report
  • April 2025
  • 89 Pages
  • Global
From
Bioreactors and Fermenters - Global Strategic Business Report - Product Thumbnail Image

Bioreactors and Fermenters - Global Strategic Business Report

  • Report
  • April 2025
  • 244 Pages
  • Global
From
Cell Line Development - Global Strategic Business Report - Product Thumbnail Image

Cell Line Development - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
Single-Use Bioprocessing - Global Strategic Business Report - Product Thumbnail Image

Single-Use Bioprocessing - Global Strategic Business Report

  • Report
  • April 2025
  • 197 Pages
  • Global
From
From
Bioprocess Monitoring - Global Strategic Business Report - Product Thumbnail Image

Bioprocess Monitoring - Global Strategic Business Report

  • Report
  • April 2025
  • 170 Pages
  • Global
From
Cell Culture Vessels - Global Strategic Business Report - Product Thumbnail Image

Cell Culture Vessels - Global Strategic Business Report

  • Report
  • April 2025
  • 387 Pages
  • Global
From
Cell Culture Media - Global Strategic Business Report - Product Thumbnail Image

Cell Culture Media - Global Strategic Business Report

  • Report
  • April 2025
  • 480 Pages
  • Global
From
Loading Indicator

Single Use Bioreactors (SUBs) are bioreactors that are designed for a single use and then disposed of. They are used in biotechnology for the production of biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins. SUBs are typically made of plastic and are pre-sterilized, eliminating the need for cleaning and sterilization between batches. This makes them ideal for rapid scale-up and production of biopharmaceuticals. SUBs also offer advantages such as reduced risk of contamination, improved process control, and reduced capital costs. The SUB market is growing rapidly due to the increasing demand for biopharmaceuticals and the need for rapid scale-up and production. SUBs are becoming increasingly popular in the biotechnology industry due to their cost-effectiveness and convenience. Some companies in the SUB market include Sartorius, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, and Pall Corporation. Show Less Read more